title: Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.
authors.affiliation: Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
authors.forename: D P
authors.initials: DP
authors.lastname: Chew
authors.forename: D L
authors.initials: DL
authors.lastname: Bhatt
authors.forename: M A
authors.initials: MA
authors.lastname: Robbins
authors.forename: D
authors.initials: D
authors.lastname: Mukherjee
authors.forename: M
authors.initials: M
authors.lastname: Roffi
authors.forename: J P
authors.initials: JP
authors.lastname: Schneider
authors.forename: E J
authors.initials: EJ
authors.lastname: Topol
authors.forename: S G
authors.initials: SG
authors.lastname: Ellis
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000378:metabolism*; D000077144:Clopidogrel; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000097:blood / Q000401:mortality / Q000628:therapy*; D009820:Ohio; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D011292:Premedication; D012042:Registries; D015607:Stents; D016019:Survival Analysis; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D002097:C-Reactive Protein; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin